BIOGEN INC. reports stock transactions
- Sean Godbout, Chief Accounting Officer, acquired 27 shares on 10/02/2026.
- Disposed of 8 shares on 10/02/2026.
- Received 985 restricted stock units on 10/01/2026.
Sean Godbout
BIIB
BIOGEN INC. SEC filings
Every EDGAR filing for BIOGEN INC. (BIIB), newest first, with AI summaries and stories.
- Ticker
- BIIB
- CIK
- 875045
- Latest filing
- Oct 5
Next: earnings expected ~Oct 30 · 10-Q expected ~Oct 30 (deadline Nov 9)
Insider activity
No open-market insider buys in the last 30 days.
Also: 2 grants or exercises.
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
ROUTINE4BIOGEN INC.BIIBLIVE ROUTINE4BIOGEN INC.BIIBLIVE Michael Parini, insider filing for BIIB
Michael Parini, reporting
ROUTINE3BIOGEN INC.BIIBLIVE Michael Parini, new insider at BIIB
Michael Parini, reporting
ROUTINESCHEDULE 13G/ABIOGEN INC.BIIBLIVE Ownership stake disclosure by FMR LLC (amended)
FMR LLC, filed by
ROUTINE4BIOGEN INC.BIIBLIVE Lloyd Minor, insider filing for BIIB
Lloyd Minor, reporting
ROUTINE144BIOGEN INC.BIIBLIVE Lloyd Minor, planned sale of BIIB shares
Lloyd Minor, reporting
ROUTINE144BIOGEN INC.BIIBLIVE Lloyd Minor, planned sale of BIIB shares
Lloyd Minor, reporting
NOTABLE10-QBIOGEN INC.BIIBLIVE ROUTINE8-KBIOGEN INC.BIIBLIVE ROUTINE8-KBIOGEN INC.BIIBLIVE ROUTINE4BIOGEN INC.BIIBLIVE 9 insider filings
William A Hawkins, insider filing for BIIB
Show all 9
- 4Insider filing for BIIB
- 4Insider filing for BIIB
- 4Insider filing for BIIB
- 4Insider filing for BIIB
- 4Insider filing for BIIB
- 4Insider filing for BIIB
- 4Insider filing for BIIB
- 4Insider filing for BIIB
- 4Insider filing for BIIB
William A Hawkins, reporting
ROUTINE8-KBIOGEN INC.BIIBLIVE ROUTINE8-K/ABIOGEN INC.BIIBLIVE ROUTINESCHEDULE 13G/ABIOGEN INC.BIIBLIVE Ownership stake disclosure by FMR LLC (amended)
FMR LLC, filed by
NOTABLESCHEDULE 13D/AApellis Pharmaceuticals, Inc.APLSLIVE Ownership stake disclosure by BIOGEN INC. (amended)
BIOGEN INC., filed by
ROUTINE8-KBIOGEN INC.BIIBLIVE ROUTINESC TO-T/AApellis Pharmaceuticals, Inc.APLSLIVE BIOGEN INC., filed by
ROUTINESC TO-T/AApellis Pharmaceuticals, Inc.APLSLIVE BIOGEN INC., filed by
ROUTINESC TO-T/AApellis Pharmaceuticals, Inc.APLSLIVE BIOGEN INC., filed by
ROUTINESCHEDULE 13G/ABIOGEN INC.BIIBLIVE Ownership stake disclosure by FMR LLC (amended)
FMR LLC, filed by
ROUTINE4BIOGEN INC.BIIBLIVE Adam Keeney, insider filing for BIIB
Adam Keeney, reporting
ROUTINESCHEDULE 13GBIOGEN INC.BIIBLIVE Ownership stake disclosure by VANGUARD CAPITAL MANAGEMENT LLC
VANGUARD CAPITAL MANAGEMENT LLC, filed by
NOTABLE10-QBIOGEN INC.BIIBLIVE ROUTINE8-KBIOGEN INC.BIIBLIVE ROUTINEARSBIOGEN INC.BIIBLIVE ROUTINEDEFA14ABIOGEN INC.BIIBLIVE ROUTINEDEF 14ABIOGEN INC.BIIBLIVE NOTABLESC TO-TApellis Pharmaceuticals, Inc.APLSLIVE BIOGEN INC., filed by
ROUTINESC TO-CApellis Pharmaceuticals, Inc.APLSLIVE BIOGEN INC., filed by
ROUTINE3Apellis Pharmaceuticals, Inc.APLSLIVE BIOGEN INC., new insider at APLS
BIOGEN INC., reporting
NOTABLESCHEDULE 13DApellis Pharmaceuticals, Inc.APLSLIVE Ownership stake disclosure by BIOGEN INC.
BIOGEN INC., filed by
ROUTINE8-KBIOGEN INC.BIIBLIVE ROUTINESC TO-CApellis Pharmaceuticals, Inc.APLSLIVE BIOGEN INC., filed by
ROUTINE4BIOGEN INC.BIIBLIVE Sean Godbout, insider filing for BIIB
Sean Godbout, reporting
ROUTINESC TO-CApellis Pharmaceuticals, Inc.APLSLIVE BIOGEN INC., filed by
ROUTINE8-KBIOGEN INC.BIIBLIVE ROUTINESC TO-CApellis Pharmaceuticals, Inc.APLSLIVE BIOGEN INC., filed by
ROUTINESCHEDULE 13G/ABIOGEN INC.BIIBLIVE Ownership stake disclosure by VANGUARD GROUP INC (amended)
VANGUARD GROUP INC, filed by
ROUTINE8-KBIOGEN INC.BIIBLIVE ROUTINE4BIOGEN INC.BIIBLIVE 3 insider filings
Christopher Viehbacher, insider filing for BIIB
Show all 3
- 4Insider filing for BIIB
- 4Insider filing for BIIB
- 4Insider filing for BIIB
Christopher Viehbacher, reporting